Format

Send to

Choose Destination
Rheum Dis Clin North Am. 2009 Feb;35(1):183-99. doi: 10.1016/j.rdc.2009.03.009.

Infectious complications of biologic agents.

Author information

1
Department of Rheumatology, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid 28046, Spain. emartinmola.hulp@salud.madrid.org

Abstract

Infection is a frequent complication in rheumatoid arthritis (RA) and other autoimmune diseases. Since 2000, the spectrum of therapeutic possibilities (ie, biologic agents) for treating RA has expanded rapidly and many safety reports of patients treated with these drugs have been published. In most studies, biologics are associated with an increased incidence of infections with the use of tumor necrosis factor antagonists. Reported risks for developing infection differ among studies. This article provides an overview of which studies the authors consider the most relevant.

PMID:
19481004
DOI:
10.1016/j.rdc.2009.03.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center